Experts recap key takeaways from the SWOG Spring Group Meeting.

ASCO Daily News Editor-in-Chief John Sweetenham, MD, FRCP, FACP, discusses notable hematology abstracts from the 2017 ASCO Annual Meeting.

Roy S. Herbst, MD, PhD, provides updates on immunotherapy for cancer treatment.

Steven E. Finkelstein, MD, discusses the latest recommendations from the prostate cancer RADAR II Working Group.

George D. Demetri, MD, discusses the evolving treatment landscape of advanced soft tissue sarcoma.

Susana M. Campos, MD, MPH, provides an update on PARP inhibitors for ovarian cancer.

Dr. Catherine Lai, of the National Heart, Lung, and Blood Institute at the National Institutes of Health, discusses new immunotherapies aimed at decreasing relapse rates in patients with leukemia.

Dr. Heather McArthur, medical director of breast oncology at Cedars-Sinai Medical Center, discusses combination radiotherapy/immunotherapy treatments aimed at increasing survival outcomes of patients with breast cancer that has metastasized to the brain.